Skip to main content

Local News for Farmingville, Holbrook, Holtsville, Lake Grove, and Lake Ronkonkoma

Breaking News

Complete a simple submission form to share your information now.

Support Local Journalism

Now, more than ever, the world needs trustworthy reporting—but good journalism isn’t free. Please support us by making a contribution.

FRIDAY, Jan. 21, 2022 (HealthDay News) -- Among adults with overweight or obesity, once-weekly subcutaneous semaglutide plus counseling for diet and physical activity results in significantly greater weight loss at 68 weeks than once-daily subcutaneous liraglutide, according to a study published in the Jan. 11 issue of the Journal of the American Medical Association. Read more from OnSachem News.